OverviewSuggest Edit

Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. It offers medical and surgical equipment, pharmaceutical products, back office products, orthopedic products, and instruments, such as cotton balls, exam tables, diagnostic lights, tongue depressors, ECG equipment and supplies, spirometry equipment, rapid lab testing equipment and supplies, disposable items, and more. The Company’s customers include physicians, obstetricians and gynecologists, pediatricians, surgeons, vocational schools, correctional complexes, state and Government agencies, occupational and industrial healthcare facilities, and other specialty practices in the United States.

TypePublic
Founded1995
HQWixom, US
Websiterockwellmed.com
Employee Ratings2.5

Latest Updates

Employees (est.) (Dec 2018)269(-10%)
Revenue (FY, 2018)$63.4 M(+11%)
Share Price (Jun 2019)$4.6 (+9%)

Key People/Management at Rockwell Medical

Robert Chioini

Robert Chioini

Founder, Chairman, CEO & President
Thomas Klema

Thomas Klema

Vp & CFO
Show more

Rockwell Medical Office Locations

Rockwell Medical has an office in Wixom
Wixom, US (HQ)
30142 Wixom Rd
Show all (1)

Rockwell Medical Financials and Metrics

Rockwell Medical Revenue

Embed Graph
View revenue for all periods
Rockwell Medical's revenue was reported to be $63.39 m in FY, 2018
USD

Revenue (Q2, 2019)

14.8m

Gross profit (Q2, 2019)

733.1k

Gross profit margin (Q2, 2019), %

4.9%

Net income (Q2, 2019)

(10.3m)

EBIT (Q2, 2019)

(10.4m)

Market capitalization (10-Jun-2019)

263.2m

Closing stock price (10-Jun-2019)

4.6

Cash (30-Jun-2019)

21.4m
Rockwell Medical's current market capitalization is $263.2 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

52.4m54.2m55.4m53.3m57.3m63.4m

Revenue growth, %

3%2%(4%)

Cost of goods sold

45.7m11.9m46.4m46.5m53.6m65.0m

Gross profit

6.7m42.3m8.9m6.8m3.7m(1.6m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q2, 2019

Revenue

13.1m13.0m13.0m13.7m13.9m13.0m14.4m13.6m13.5m12.8m14.6m13.2m14.6m14.9m14.9m16.7m14.8m

Cost of goods sold

11.5m11.3m11.0m11.5m11.6m10.9m11.9m11.9m12.0m11.2m12.2m11.7m13.6m15.7m18.9m14.7m14.1m

Gross profit

1.6m1.7m2.0m2.3m2.3m2.1m2.5m1.7m1.5m1.6m2.4m1.5m1.1m(720.5k)(4.0m)2.0m733.1k

Gross profit Margin, %

12%13%15%17%17%16%17%12%11%12%16%11%7%(5%)(27%)12%5%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

11.9m65.8m31.2m17.2m8.4m22.7m

Accounts Receivable

Inventories

2.8m3.9m7.9m12.1m7.6m4.0m

Current Assets

31.9m94.7m84.6m78.5m48.8m46.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q2, 2019

Cash

21.2m661.1k2.9m3.0m63.3m37.1m33.2m30.0m23.8m19.3m11.9m8.3m3.9m3.3m1.7m4.3m21.4m

Accounts Receivable

2.2m

Inventories

2.8m2.9m2.8m3.0m5.2m6.3m7.4m9.2m11.0m11.8m13.4m13.8m14.9m5.5m4.5m4.6m4.0m

Current Assets

38.9m22.3m21.7m19.9m94.0m88.4m87.9m85.8m84.0m79.8m74.8m63.8m61.2m41.2m35.5m32.1m48.3m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(8.3m)(21.3m)(5.8m)(19.8m)(32.1m)

Depreciation and Amortization

1.0m996.3k822.3k762.4k514.4k650.1k

Inventories

(150.0k)(835.6k)

Accounts Payable

(6.1m)(3.4m)1.9m(1.6m)269.9k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q2, 2019

Net Income

(3.2m)(14.9m)(3.7m)(2.5m)(2.4m)(4.8m)(5.4m)(4.6m)(4.7m)(17.8m)(22.7m)(19.0m)

Depreciation and Amortization

752.4k257.8k506.5k767.4k207.9k408.3k608.2k200.1k396.0k583.5k130.2k259.1k384.8k129.1k281.3k467.0k380.4k

Inventories

15.5k(2.4m)59.4k1.3m3.7m66.1k

Accounts Payable

(7.7m)(3.6m)(2.4m)425.3k981.0k(598.4k)(1.9m)(2.0m)(1.7m)(209.2k)
USDY, 2019

Financial Leverage

1.9 x
Show all financial metrics

Rockwell Medical Online and Social Media Presence

Embed Graph

Rockwell Medical News and Updates

Rockwell Medical, Inc. to Discuss Second Quarter 2019 Financial Results on August 8, 2019

WIXOM, Mich., July 29, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 second quarter financial results on Thursday, August 8, 2019, after the close of the U.S. financial markets.

Rockwell Medical Announces Adjournment of Annual Meeting of Shareholders

- Adjournment solely to vote on Delaware reincorporation Proposal 3(a) -

Rockwell Medical, Inc. Announces Submission of New Drug Application for I.V. Triferic®

I.V. Triferic was developed through Special Protocol Assessment with FDA based on equivalence approach to Dialysate Triferic I.V. Triferic was developed through Special Protocol Assessment with FDA based on equivalence approach to Dialysate Triferic

Rockwell Medical, Inc. Commences Commercial Sales of Dialysate Triferic® in the U.S.

Company launches first formulation in its Triferic® portfolio Company launches first formulation in its Triferic® portfolio

Rockwell Medical, Inc. to Discuss First Quarter 2019 Financial Results on May 9, 2019

WIXOM, Mich., May 02, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 first quarter financial results on Thursday, May 9, 2019, after the closing of the U.S. financial markets.

Rockwell Medical, Inc. to Present at Sidoti & Company LLC Spring 2019 Investor Conference

WIXOM, Mich., March 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the Sidoti & Company LLC Spring 2019 Investor Conference as follows:
Show more

Rockwell Medical Frequently Asked Questions

  • When was Rockwell Medical founded?

    Rockwell Medical was founded in 1995.

  • Who are Rockwell Medical key executives?

    Rockwell Medical's key executives are Robert Chioini and Thomas Klema.

  • How many employees does Rockwell Medical have?

    Rockwell Medical has 269 employees.

  • What is Rockwell Medical revenue?

    Latest Rockwell Medical annual revenue is $63.4 m.

  • What is Rockwell Medical revenue per employee?

    Latest Rockwell Medical revenue per employee is $235.6 k.

  • Who are Rockwell Medical competitors?

    Competitors of Rockwell Medical include Nikkiso, Aerogen and Abbott.

  • Where is Rockwell Medical headquarters?

    Rockwell Medical headquarters is located at 30142 Wixom Rd, Wixom.

  • Where are Rockwell Medical offices?

    Rockwell Medical has an office in Wixom.

  • How many offices does Rockwell Medical have?

    Rockwell Medical has 1 office.